Pancreatic exocrine insufficiency.
2/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
no financial support for the research, authorship, and/or publication of this article
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Pancreatic enzyme replacement therapy remains the cornerstone of treatment, with currently available porcine-derived formulations demonstrating high efficacy, although future research should explore alternative enzyme sources and novel therapeutic approaches. [FUNDING] The authors received no financial support for the research, authorship, and/or publication of this article.
OpenAlex 토픽 ·
Pancreatitis Pathology and Treatment
Pancreatic function and diabetes
Neuroendocrine Tumor Research Advances
[UNLABELLED] Pancreatic exocrine insufficiency (PEI) is a common but frequently under-recognised condition that often presents with non-specific gastrointestinal symptoms, which may be subtle in early
APA
Daniel de la Iglesia, Miroslav Vujasinović, et al. (2026). Pancreatic exocrine insufficiency.. EClinicalMedicine, 94, 103880. https://doi.org/10.1016/j.eclinm.2026.103880
MLA
Daniel de la Iglesia, et al.. "Pancreatic exocrine insufficiency.." EClinicalMedicine, vol. 94, 2026, pp. 103880.
PMID
42011215 ↗
Abstract 한글 요약
[UNLABELLED] Pancreatic exocrine insufficiency (PEI) is a common but frequently under-recognised condition that often presents with non-specific gastrointestinal symptoms, which may be subtle in early stages. Evidence from studies published between 2000 and 2026 indicates that, although the leading causes of PEI are pancreatic diseases such as chronic or autoimmune pancreatitis, pancreatic cancer, and pancreatic surgery, it is also increasingly recognised in common conditions including diabetes mellitus and ageing. Clinically, PEI should be suspected in patients presenting with diarrhoea, steatorrhoea, bloating, weight loss, or abdominal discomfort, particularly when malnutrition or micronutrient deficiencies are present. These deficiencies are associated with clinically relevant complications, including osteoporosis and cardiovascular disease, highlighting the importance of timely diagnosis and appropriate management. Pancreatic enzyme replacement therapy remains the cornerstone of treatment, with currently available porcine-derived formulations demonstrating high efficacy, although future research should explore alternative enzyme sources and novel therapeutic approaches.
[FUNDING] The authors received no financial support for the research, authorship, and/or publication of this article.
[FUNDING] The authors received no financial support for the research, authorship, and/or publication of this article.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenergetic images.
- Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outcome.
- Intrapancreatic fat deposition in the elderly: a retrospective cadaveric study with histopathological characterization.
- Evaluating deep learning models for pancreatic cancer diagnosis.
- Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study.
- Predictive prioritization of enhancers associated with pancreatic disease risk.